SCHEMBL19736840

SCHEMBL19736840

Cc1c(CO)nc2ccc(N3CCOCC3)cn12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.46
▸ ENPP2 Q13822 1/20 0.43
▸ PIK3CA P42336 1/20 0.42
▸ MTOR P42345 1/20 0.42
▸ MAPT P10636 7/20 0.41
▸ TP53 P04637 6/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ GAA P10253 4/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ SUV39H2 Q9H5I1 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19736615 0.87 SLC2A1 (0.44) SLC2A1ENPP2PIK3CAMTORMAPT
SCHEMBL19736839 0.84 SLC2A1 (0.46) SLC2A1ENPP2PIK3CAMTORMAPT
SCHEMBL19736821 0.82 SLC2A1 (0.41) SLC2A1ENPP2PIK3CAMTORMAPT
SCHEMBL19736707 0.82 SLC2A1 (0.47) SLC2A1ENPP2PIK3CAMTORMAPT
SCHEMBL19736844 0.81 AKT1 (0.46) SLC2A1ENPP2PIK3CAMAPTALDH1A1
SCHEMBL19736645 0.76 PIK3CD (0.52) SLC2A1MTORMAPTTP53KDM4E
SCHEMBL19736643 0.74 PIK3C2B (0.58) PIK3CAMTOR
SCHEMBL19736705 0.74 SLC2A1 (0.46) SLC2A1ENPP2PIK3CAMTORMAPT
SCHEMBL19495214 0.73 SLC2A1 (0.54) SLC2A1ENPP2MAPTTP53ALDH1A1
SCHEMBL19736841 0.73 AKT1 (0.44) SLC2A1ENPP2MAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3472160-B1 BICYCLIC PYRIDINE, PYRAZINE, AND PYRIMIDINE DERIVATIVES AS PI3K BETA INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-02-24 — — EP disclosed
WO-2017216292-A1 BICYCLIC PYRIDINE, PYRAZINE, AND PYRIMIDINE DERIVATIVES AS PI3K BETA INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-12-21 — — WO disclosed
Send feedback